3644 results for «2823»

Filter By

3644 results

How to face resistent hypertension: when pharmacological treatment is not an option

19 May 2026 – From EuroPCR 2026

Focused on resistant hypertension, this session explores interventional options when pharmacological treatments fall short. It discusses urgent intervention indications, complex cases involving renal artery occlusion, and the role of fractional flow reserve (FFR) in managing pan-vascular disease associated with hypertension.

Unusual NSTEMI lesions and cases

19 May 2026 – From EuroPCR 2026

This session presents a collection of unusual NSTEMI cases characterized by atypical lesion patterns and diagnostic challenges. Topics include surprising unstable angina presentations, complex ostial lesions of the left circumflex artery, and the critical role of OCT imaging in preventing adverse outcomes.

Re-intervention challenges after first aortic valve replacement

19 May 2026 – From EuroPCR 2026

Addressing the challenges of re-intervention after initial aortic valve replacement, this session highlights advanced valve-in-valve TAVI strategies, including leaflet modification techniques, management of extreme coronary obstruction risks, and complex anatomical considerations such as post-Bentall root anatomy.

Re-intervention challenges after first aortic valve replacement

Bioresorbable devices in clinical practice

19 May 2026 – From EuroPCR 2026

This session examines the evolving role of bioresorbable devices in coronary intervention, showcasing hybrid PCI strategies, novel applications in myocardial bridging, and innovative solutions for complex coronary lesions, including the use of bioadaptors and dual-device techniques.

Primary PCI in challenging anatomy

19 May 2026 – From EuroPCR 2026

Focusing on primary PCI in challenging coronary anatomies, this session covers intracoronary thrombolysis for ectasia, imaging-guided no-stent strategies in vein graft occlusions, and management of coronary aneurysms presenting with acute coronary syndromes, highlighting tailored interventional approaches.

Rescue PCI for acute or unusual left main lesions

19 May 2026 – From EuroPCR 2026

This session explores rescue PCI techniques for acute and unusual left main coronary lesions, highlighting complex cases such as left main compression syndrome in pulmonary hypertension, and challenging strategies in acute coronary syndromes with left main occlusion and anatomical variations.

Interventional therapy for hypertension

19 May 2026 – From EuroPCR 2026

This session addresses interventional therapies for hypertension, emphasizing patient selection for renal denervation and integration of this technique within comprehensive hypertension management. It also reviews available renal denervation technologies, optimal procedural approaches, and considerations for interventional treatment of renal artery stenosis.

Interventional therapy for hypertension

RESIL-Card in action: early European experience and lessons from the first users

19 May 2026 – From EuroPCR 2026

This session presents the early European experience with the RESIL-Card tool, designed to optimize interventional cardiology care pathways during crises. It includes practical insights from early adopters, updates on dissemination efforts across Europe, strategies for engaging patients and organizations, and discussions on national and EU political...

FFR- and IVUS-guided PCI of a long and calcified LAD lesion - LIVE case

19 May 2026 – From EuroPCR 2026

A 71‑year‑old man with hypertension and dyslipidemia presented with CCS class II angina and three‑vessel coronary artery disease. Functional assessment included CT‑derived micro‑FFR, angiography‑based FFR, and stress myocardial scintigraphy. The only hemodynamically significant lesion was a long, calcified lesion of the LAD.

Lesion preparation was performed with...

FFR- and IVUS-guided PCI of a long and calcified LAD lesion - LIVE case

What bench testing teaches us about real world PCI

19 May 2026 – From EuroPCR 2026

This session explores bench testing insights into real-world percutaneous coronary interventions (PCI). Topics include comparative expansion ratios of coronary stents, prognostic assessments after drug-coated balloon treatments, mechanical performance of magnesium scaffolds in bifurcations, preclinical safety and computational modeling of bioresorbable polymer-coated stents, and evaluations of commonly...

Identifying problems and solving complex anatomies during TAVI

19 May 2026 – From EuroPCR 2026

A comprehensive session on managing complex anatomies during Transcatheter Aortic Valve Implantation (TAVI), emphasizing risk markers for peri-operative complications and strategies to address difficult anatomical challenges. Real-world cases illustrate practical approaches and key learnings for handling intricate TAVI scenarios.

Complication management in CTO PCI - Part 1

19 May 2026 – From EuroPCR 2026

This session addresses complication management during chronic total occlusion (CTO) percutaneous coronary interventions. It covers strategies for unexpected coronary complications, managing tamponade without visible perforation, rescue techniques for atherectomy-related perforations, managing dry pericardial tamponade after septal branch perforation, and challenges when retrograde approaches encounter thrombosis in...

Angiography-based physiology: time to change your routine clinical practice?

20 May 2026 – From EuroPCR 2026

This session offers a critical appraisal of angiography-based physiology, with a focus on virtual fractional flow reserve (vFFR) technology. It reviews the latest clinical evidence, including insights from the FAST study programme and the FAST III randomised controlled trial. Gain a clear understanding of current guideline...

Angiography-based physiology: time to change your routine clinical practice?

When balloons fail: how to win against coronary calcium

19 May 2026 – From EuroPCR 2026

This session refines strategies to overcome undilatable calcified coronary lesions by integrating modern calcium-modification technologies into complex PCI workflows. Through multiple international case studies, it highlights approaches to achieve optimal stent expansion despite severe coronary calcium challenges.

Thrombectomy in pulmonary embolism

19 May 2026 – From EuroPCR 2026

This session addresses the critical role of mechanical thrombectomy in managing pulmonary embolism, focusing on rescue interventions in refractory massive acute cases. It explores clinical and technical challenges that extend beyond current guidelines, reviews complex cases including intermediate-high risk pulmonary embolism with peripheral embolism, intracardiac thrombosis,...

Thrombectomy in pulmonary embolism

Place of DCB in clinical practice

19 May 2026 – From EuroPCR 2026

This session explores the clinical applications of drug-coated balloons (DCB) across diverse challenging scenarios. It covers management of severely calcified nodules in acute coronary syndrome, healing of intentional dissections in chronic total occlusions using paclitaxel DCB, strategic integration of contemporary technology in complex lesion treatment, and...

Regulatory and reimbursement pathways for MedTech innovators

19 May 2026 – From EuroPCR 2026

This session provides an in-depth exploration of regulatory and reimbursement pathways critical for MedTech innovators. It covers the transition challenges from the Medical Device Directive (MDD) to the Medical Device Regulation (MDR), sharing lessons learned and success stories. The session also addresses reimbursement frameworks in the...

The thin line between success and failure in MedTech start ups - Lessons learnt

18 May 2026 – From EuroPCR 2026

This session examines critical success factors for MedTech start-ups through real-world examples, discussing challenges, investment dynamics, and the pivotal role of the Chief Medical Officer and investor syndicates in fostering sustainable growth.

Transcatheter mitral valve replacement - LIVE case

20 May 2026 – From EuroPCR 2026

A 65‑year‑old woman with obesity (BMI 38.7), prior cardiac surgery (CABG to OM and LAD in 2012), and chronic kidney disease presented with symptomatic severe mitral regurgitation (Carpentier type III: type IIIa due to calcification and type IIIb post‑MI) with moderately reduced LVEF (45%).

A transcatheter mitral...

Transcatheter mitral valve replacement - LIVE case

New frontiers: TAVI for aortic regurgitation with conventional and dedicated devices

20 May 2026 – From EuroPCR 2026

This session explores new frontiers in transcatheter aortic valve implantation (TAVI) for treating pure aortic regurgitation. It addresses the challenges inherent to this indication, reviews treatment approaches using conventional balloon-expandable and self-expandable devices, and presents recent data along with dedicated TAVI devices designed specifically for aortic...

New frontiers: TAVI for aortic regurgitation with conventional and dedicated devices
Didn’t find what you were looking for?